OSTXNYSEPharmaceutical PreparationsFiscal year ends December 31
OS Therapies Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.27−0.05 (-3.79%)
Close on Oct 19, 2026
- Market cap
- $55.76M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.58 (−31.35%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $55.76M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -26.37%
Fundamentals
- Net income
- -$39.37M
- EPS, diluted
- -$1.07
- Free cash flow
- -$14.70M
- Book value per share
- -$0.27
- Diluted shares
- 44M
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Operating income
-$37.61M
Net income
-$39.37M
EPS, diluted
-$1.07
Free cash flow
–
Reported periodTrailing twelve months